6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      C57BL/6 substrain differences in inflammatory and neuropathic nociception and genetic mapping of a major quantitative trait locus underlying acute thermal nociception

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sensitivity to different pain modalities has a genetic basis that remains largely unknown. Employing closely related inbred mouse substrains can facilitate gene mapping of nociceptive behaviors in preclinical pain models. We previously reported enhanced sensitivity to acute thermal nociception in C57BL/6J ( B6J) versus C57BL/6N ( B6N) substrains. Here, we expanded on nociceptive phenotypes and observed an increase in formalin-induced inflammatory nociceptive behaviors and paw diameter in B6J versus B6N mice (Charles River Laboratories). No strain differences were observed in mechanical or thermal hypersensitivity or in edema following the Complete Freund’s Adjuvant model of inflammatory pain, indicating specificity in the inflammatory nociceptive stimulus. In the chronic constrictive nerve injury, a model of neuropathic pain, no strain differences were observed in baseline mechanical threshold or in mechanical hypersensitivity up to one month post-chronic constrictive nerve injury. We replicated the enhanced thermal nociception in the 52.5°C hot plate test in B6J versus B6N mice from The Jackson Laboratory. Using a B6J × B6N-F2 cross (N = 164), we mapped a major quantitative trait locus underlying hot plate sensitivity to chromosome 7 that peaked at 26 Mb (log of the odds [LOD] = 3.81, p < 0.01; 8.74 Mb-36.50 Mb) that was more pronounced in males. Genes containing expression quantitative trait loci associated with the peak nociceptive marker that are implicated in pain and inflammation include Ryr1, Cyp2a5, Pou2f2, Clip3, Sirt2, Actn4, and Ltbp4 (false discovery rate < 0.05). Future studies involving positional cloning and gene editing will determine the quantitative trait gene(s) and potential pleiotropy of this locus across pain modalities.

          Related collections

          Most cited references52

          • Record: found
          • Abstract: not found
          • Article: not found

          R/qtl: QTL mapping in experimental crosses

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Olfactory exposure to males, including men, causes stress and related analgesia in rodents.

            We found that exposure of mice and rats to male but not female experimenters produces pain inhibition. Male-related stimuli induced a robust physiological stress response that results in stress-induced analgesia. This effect could be replicated with T-shirts worn by men, bedding material from gonadally intact and unfamiliar male mammals, and presentation of compounds secreted from the human axilla. Experimenter sex can thus affect apparent baseline responses in behavioral testing.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines.

                Bookmark

                Author and article information

                Journal
                Mol Pain
                Mol Pain
                MPX
                spmpx
                Molecular Pain
                SAGE Publications (Sage CA: Los Angeles, CA )
                1744-8069
                05 February 2019
                2019
                : 15
                : 1744806918825046
                Affiliations
                [1 ]Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA
                [2 ]Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA
                [3 ]Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA
                [4 ]Translational Research Initiative for Pain and Neuropathy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA
                [5 ]Program in Biomolecular Pharmacology, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA
                [6 ]Department of Medicine, Computational Biomedicine, Bioinformatics Program, Boston University, Boston, MA, USA
                [7 ]Department of Medicine, Computational Biomedicine, Boston University School of Medicine, Boston, MA, USA
                [8 ]Department of Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, Memphis, TN, USA
                Author notes
                [*]Camron D Bryant, Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, 72 E. Concord Street, L-606C, Boston, MA 02118, USA. Email: camron@ 123456bu.edu
                Article
                10.1177_1744806918825046
                10.1177/1744806918825046
                6365993
                30632432
                665a56e2-457a-4a9f-9641-d4889df27294
                © The Author(s) 2019

                Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ( http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ( https://us.sagepub.com/en-us/nam/open-access-at-sage).

                History
                : 2 October 2018
                : 26 November 2018
                : 21 December 2018
                Funding
                Funded by: NIH/NIGMS, FundRef ;
                Award ID: T32GM008541
                Funded by: NIH/NCI, FundRef ;
                Award ID: R01CA221260
                Funded by: NIH/NIDA, FundRef ;
                Award ID: R01DA039168
                Award ID: R21DA038738
                Categories
                Research Article
                Custom metadata
                January-December 2019

                Molecular medicine
                pain genetics,rodents,genome-wide,reduced complexity cross,c57bl/6 substrains
                Molecular medicine
                pain genetics, rodents, genome-wide, reduced complexity cross, c57bl/6 substrains

                Comments

                Comment on this article